FRCA Notes


Phenylephrine


  • Phenylephrine is a directly-acting sympathomimetic with potent alpha-agonist actions and no beta activity
  • Intravenous bolus dose(s) or infusion to combat vasoplegia-induced hypotension associated with anaesthesia
  • Can be used by IM and SC routes too
  • As an nasal decongestant (although evidence suggests oral consumption not really very effective)
  • As a mydriatic agent

Presentation

  • Presents as a clear solution of 0.1 - 10mg/ml
  • Stronger concentrations may be used by perfusionists during cardiopulmonary bypass

Absorption

  • IV administration results in a rapid rise in BP that lasts 5-10mins
  • IM or SC use takes 15 minutes to work but lasts up to 1hr

Metabolism

  • Metabolised in the liver by MAO to unknown products

Cardiovascular

  • Raised SVR and therefore BP
  • May cause a reflex bradycardia (and therefore a drop in cardiac output)
  • Not arrhythmogenic

Neurological

  • Does not cross BBB
  • Increases cerebral blood flow but cerebral tissue oxygen saturation falls (Anaesthesia, 2023)

Renal

  • Reduction in renal blood flow due to vasoconstriction

Uteroplacental

  • Preferred to ephedrine for maternal hypotension during LSCS as evidence suggests phenylephrine is associated with a more favourable cord gas profile